Loading…

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hep...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2020-05, Vol.21 (11), p.3863
Main Authors: Fujii, Hideki, Kawada, Norifumi, Japan Study Group Of Nafld Jsg-Nafld
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3
cites cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3
container_end_page
container_issue 11
container_start_page 3863
container_title International journal of molecular sciences
container_volume 21
creator Fujii, Hideki
Kawada, Norifumi
Japan Study Group Of Nafld Jsg-Nafld
description Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.
doi_str_mv 10.3390/ijms21113863
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c3223d68522949c5b43c9404ff157097</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c3223d68522949c5b43c9404ff157097</doaj_id><sourcerecordid>2408951776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</originalsourceid><addsrcrecordid>eNpdkcFrFDEUh4NYbG29eZaAFw-uTfIyM8lFKNXqwtJCqeeQSV66WWYnNZkp9L83dmvZesoj7-N7yfsR8p6zLwCancbNtgjOOagWXpEjLoVYMNZ2r_fqQ_K2lA1jAkSj35BDEFI1CtQRubpZI71OA9IU6HIs8xBHeo0llsmODqkdPf0WbY8TFlpbl2m0g0vrNERHL-w0PdBVvMdcoYK24Ak5CHYo-O7pPCa_Lr7fnP9crK5-LM_PVgvXSDktQrDSKwaddUH4VmnJlBbcSWDolAu970GCZ85b4Zi0jfbetgIl8ywEgXBMljuvT3Zj7nLc2vxgko3m8SLlW2PzFN2AxoEQUGc0QmipXdNLcHWeDIE3HdNddX3due7mfove4ThlO7yQvuyMcW1u073pgAsNvAo-PQly-j1jmcw2FofDYEdMczFCMs21BM4q-vE_dJPmXHf6SCnd8K5rK_V5R7mcSskYnh_DmfmbutlPveIf9j_wDP-LGf4ATXynlA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2408951776</pqid></control><display><type>article</type><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><source>ProQuest - Publicly Available Content Database</source><source>PubMed Central</source><creator>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld</creator><creatorcontrib>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld ; Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><description>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113863</identifier><identifier>PMID: 32485838</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Biopsy ; Cell activation ; Cirrhosis ; Cytokines ; Diabetes ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - genetics ; Diabetes Mellitus - metabolism ; Energy metabolism ; Extracellular matrix ; Fatty liver ; Fibrosis ; Genetic factors ; Glucose ; hepatic fibrosis ; Hepatocellular carcinoma ; Humans ; Hyperglycemia ; Immune system ; Inflammation ; Insulin ; Insulin Resistance ; Kinases ; Liver ; Liver cancer ; Liver cirrhosis ; Liver diseases ; Metabolism ; Molecular modelling ; Mortality ; Non-alcoholic Fatty Liver Disease - epidemiology ; Non-alcoholic Fatty Liver Disease - genetics ; Non-alcoholic Fatty Liver Disease - metabolism ; Obesity ; Proteins ; Review ; Steatosis ; stellate cell ; Tumor necrosis factor-TNF</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3863</ispartof><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</citedby><cites>FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</cites><orcidid>0000-0003-1267-9623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2408951776/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2408951776?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32485838$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fujii, Hideki</creatorcontrib><creatorcontrib>Kawada, Norifumi</creatorcontrib><creatorcontrib>Japan Study Group Of Nafld Jsg-Nafld</creatorcontrib><creatorcontrib>Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</description><subject>Animals</subject><subject>Biopsy</subject><subject>Cell activation</subject><subject>Cirrhosis</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - genetics</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Energy metabolism</subject><subject>Extracellular matrix</subject><subject>Fatty liver</subject><subject>Fibrosis</subject><subject>Genetic factors</subject><subject>Glucose</subject><subject>hepatic fibrosis</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Kinases</subject><subject>Liver</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Liver diseases</subject><subject>Metabolism</subject><subject>Molecular modelling</subject><subject>Mortality</subject><subject>Non-alcoholic Fatty Liver Disease - epidemiology</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Non-alcoholic Fatty Liver Disease - metabolism</subject><subject>Obesity</subject><subject>Proteins</subject><subject>Review</subject><subject>Steatosis</subject><subject>stellate cell</subject><subject>Tumor necrosis factor-TNF</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkcFrFDEUh4NYbG29eZaAFw-uTfIyM8lFKNXqwtJCqeeQSV66WWYnNZkp9L83dmvZesoj7-N7yfsR8p6zLwCancbNtgjOOagWXpEjLoVYMNZ2r_fqQ_K2lA1jAkSj35BDEFI1CtQRubpZI71OA9IU6HIs8xBHeo0llsmODqkdPf0WbY8TFlpbl2m0g0vrNERHL-w0PdBVvMdcoYK24Ak5CHYo-O7pPCa_Lr7fnP9crK5-LM_PVgvXSDktQrDSKwaddUH4VmnJlBbcSWDolAu970GCZ85b4Zi0jfbetgIl8ywEgXBMljuvT3Zj7nLc2vxgko3m8SLlW2PzFN2AxoEQUGc0QmipXdNLcHWeDIE3HdNddX3due7mfove4ThlO7yQvuyMcW1u073pgAsNvAo-PQly-j1jmcw2FofDYEdMczFCMs21BM4q-vE_dJPmXHf6SCnd8K5rK_V5R7mcSskYnh_DmfmbutlPveIf9j_wDP-LGf4ATXynlA</recordid><startdate>20200529</startdate><enddate>20200529</enddate><creator>Fujii, Hideki</creator><creator>Kawada, Norifumi</creator><creator>Japan Study Group Of Nafld Jsg-Nafld</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1267-9623</orcidid></search><sort><creationdate>20200529</creationdate><title>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</title><author>Fujii, Hideki ; Kawada, Norifumi ; Japan Study Group Of Nafld Jsg-Nafld</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Biopsy</topic><topic>Cell activation</topic><topic>Cirrhosis</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - genetics</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Energy metabolism</topic><topic>Extracellular matrix</topic><topic>Fatty liver</topic><topic>Fibrosis</topic><topic>Genetic factors</topic><topic>Glucose</topic><topic>hepatic fibrosis</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Kinases</topic><topic>Liver</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Liver diseases</topic><topic>Metabolism</topic><topic>Molecular modelling</topic><topic>Mortality</topic><topic>Non-alcoholic Fatty Liver Disease - epidemiology</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Non-alcoholic Fatty Liver Disease - metabolism</topic><topic>Obesity</topic><topic>Proteins</topic><topic>Review</topic><topic>Steatosis</topic><topic>stellate cell</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fujii, Hideki</creatorcontrib><creatorcontrib>Kawada, Norifumi</creatorcontrib><creatorcontrib>Japan Study Group Of Nafld Jsg-Nafld</creatorcontrib><creatorcontrib>Japan Study Group of NAFLD (JSG-NAFLD)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest - Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fujii, Hideki</au><au>Kawada, Norifumi</au><au>Japan Study Group Of Nafld Jsg-Nafld</au><aucorp>Japan Study Group of NAFLD (JSG-NAFLD)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-29</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3863</spage><pages>3863-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves "direct" and "indirect" pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32485838</pmid><doi>10.3390/ijms21113863</doi><orcidid>https://orcid.org/0000-0003-1267-9623</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-05, Vol.21 (11), p.3863
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_c3223d68522949c5b43c9404ff157097
source ProQuest - Publicly Available Content Database; PubMed Central
subjects Animals
Biopsy
Cell activation
Cirrhosis
Cytokines
Diabetes
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus - epidemiology
Diabetes Mellitus - genetics
Diabetes Mellitus - metabolism
Energy metabolism
Extracellular matrix
Fatty liver
Fibrosis
Genetic factors
Glucose
hepatic fibrosis
Hepatocellular carcinoma
Humans
Hyperglycemia
Immune system
Inflammation
Insulin
Insulin Resistance
Kinases
Liver
Liver cancer
Liver cirrhosis
Liver diseases
Metabolism
Molecular modelling
Mortality
Non-alcoholic Fatty Liver Disease - epidemiology
Non-alcoholic Fatty Liver Disease - genetics
Non-alcoholic Fatty Liver Disease - metabolism
Obesity
Proteins
Review
Steatosis
stellate cell
Tumor necrosis factor-TNF
title The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A03%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Insulin%20Resistance%20and%20Diabetes%20in%20Nonalcoholic%20Fatty%20Liver%20Disease&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Fujii,%20Hideki&rft.aucorp=Japan%20Study%20Group%20of%20NAFLD%20(JSG-NAFLD)&rft.date=2020-05-29&rft.volume=21&rft.issue=11&rft.spage=3863&rft.pages=3863-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113863&rft_dat=%3Cproquest_doaj_%3E2408951776%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c544t-ffa4d8037acf2d689408921c430ec8cfbdb343d0cda2c04a59dda62e40d0ff2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2408951776&rft_id=info:pmid/32485838&rfr_iscdi=true